Gracell Biotechnologies Inc. (GRCL:NASDAQ) jumped higher at $3.81, a gain of 27%. The stock got featured on our News Catalysts scanner on Tue, Jun 20, 2023 at 09:53 AM in the 'BIOTECH' category. From Fri, Jun 16, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Wed, Jun 14, 2023 at $6.99 with a volume of 1M+.
About Gracell Biotechnologies Inc. (GRCL:NASDAQ)
Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of...
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
- Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
- VBI Vaccines Inc. (VBIV:NASDAQ), 75%
- Renalytix AI plc (RNLX:NASDAQ), 43.84%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
- Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
- Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
- PainReform Ltd. (PRFX:NASDAQ), 27.06%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%